{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:58:22Z","timestamp":1790895502796,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Provincial Science and Technology Department","award":["JCZRQN202500628"],"award-info":[{"award-number":["JCZRQN202500628"]}]},{"name":"the Natural Science Foundation of Hubei Province","award":["2024AFB361"],"award-info":[{"award-number":["2024AFB361"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01258-7","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:06:01Z","timestamp":1783562761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PDIA6 exacerbates hepatocellular carcinoma via enhancing proteasome-dependent degradation of AKAP12"],"prefix":"10.1007","volume":"49","author":[{"given":"Rucheng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1258_CR1","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","volume":"31","author":"SY Hwang","year":"2025","unstructured":"S.Y. Hwang et al., Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin. Mol. Hepatol. 31, S228\u2013S254 (2025). https:\/\/doi.org\/10.3350\/cmh.2024.0824","journal-title":"Clin. Mol. Hepatol."},{"key":"1258_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/s0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"S.L. Chan et al., The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet (London England). 406, 731\u2013778 (2025). https:\/\/doi.org\/10.1016\/s0140-6736(25)01042-6","journal-title":"Lancet (London England)"},{"key":"1258_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","volume":"22","author":"YH Yeo","year":"2025","unstructured":"Y.H. Yeo et al., Current and emerging strategies for the prevention of hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 22, 173\u2013190 (2025). https:\/\/doi.org\/10.1038\/s41575-024-01021-z","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1258_CR4","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"A.G. Singal, F. Kanwal, J.M. Llovet, Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat. Rev. Clin. Oncol. 20, 864\u2013884 (2023). https:\/\/doi.org\/10.1038\/s41571-023-00825-3","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1258_CR5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/gutjnl-2025-334928","volume":"74","author":"M Pinter","year":"2025","unstructured":"M. Pinter, C.A.M. Fulgenzi, D.J. Pinato, B. Scheiner, Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction. Gut. 74, 1178\u20131188 (2025). https:\/\/doi.org\/10.1136\/gutjnl-2025-334928","journal-title":"Gut"},{"key":"1258_CR6","doi-asserted-by":"publisher","first-page":"188391","DOI":"10.1016\/j.bbcan.2020.188391","volume":"1874","author":"Y Zhao","year":"2020","unstructured":"Y. Zhao, Y.N. Zhang, K.T. Wang, L. Chen, Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy. Biochim. et Biophys. acta Reviews cancer. 1874, 188391 (2020). https:\/\/doi.org\/10.1016\/j.bbcan.2020.188391","journal-title":"Biochim. et Biophys. acta Reviews cancer"},{"key":"1258_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2024.01.011","volume":"80","author":"P Tabrizian","year":"2024","unstructured":"P. Tabrizian, M. Abdelrahim, M. Schwartz, Immunotherapy and transplantation for hepatocellular carcinoma. J. Hepatol. 80, 822\u2013825 (2024). https:\/\/doi.org\/10.1016\/j.jhep.2024.01.011","journal-title":"J. Hepatol."},{"key":"1258_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Y. Wang, B. Deng, Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 42, 629\u2013652 (2023). https:\/\/doi.org\/10.1007\/s10555-023-10084-4","journal-title":"Cancer Metastasis Rev."},{"key":"1258_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2019.114428","volume":"460","author":"S Chen","year":"2019","unstructured":"S. Chen, Q. Cao, W. Wen, H. Wang, Targeted therapy for hepatocellular carcinoma: Challenges and opportunities. Cancer Lett. 460, 1\u20139 (2019). https:\/\/doi.org\/10.1016\/j.canlet.2019.114428","journal-title":"Cancer Lett."},{"key":"1258_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41388-024-02977-7","volume":"43","author":"Z Feng","year":"2024","unstructured":"Z. Feng et al., O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation. Oncogene. 43, 1149\u20131159 (2024). https:\/\/doi.org\/10.1038\/s41388-024-02977-7","journal-title":"Oncogene"},{"key":"1258_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41419-023-05747-7","volume":"14","author":"J Tang","year":"2023","unstructured":"J. Tang, G. Long, L. Xiao, L. Zhou, USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through \u03b2-catenin stabilization. Cell Death Dis. 14, 360 (2023). https:\/\/doi.org\/10.1038\/s41419-023-05747-7","journal-title":"Cell Death Dis."},{"key":"1258_CR12","doi-asserted-by":"publisher","first-page":"e2510576122","DOI":"10.1073\/pnas.2510576122","volume":"122","author":"Y Yuan","year":"2025","unstructured":"Y. Yuan et al., USP14-mediated metabolic competition impairs CD8\u2009+\u2009T cell immunosurveillance in hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A. 122, e2510576122 (2025). https:\/\/doi.org\/10.1073\/pnas.2510576122","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1258_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3727\/096504016X14761811155298","volume":"25","author":"HP Cheng","year":"2017","unstructured":"H.P. Cheng, Q. Liu, Y. Li, X.D. Li, C.Y. Zhu, The Inhibitory Effect of PDIA6 Downregulation on Bladder Cancer Cell Proliferation and Invasion. Oncol. Res. 25, 587\u2013593 (2017). https:\/\/doi.org\/10.3727\/096504016X14761811155298","journal-title":"Oncol. Res."},{"key":"1258_CR14","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3171\/2016.5.JNS152831","volume":"126","author":"TW Kim","year":"2017","unstructured":"T.W. Kim et al., PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells. J. Neurosurg. 126, 1829\u20131838 (2017). https:\/\/doi.org\/10.3171\/2016.5.JNS152831","journal-title":"J. Neurosurg."},{"key":"1258_CR15","doi-asserted-by":"publisher","unstructured":"Y. Ma et al., PDIA6 promotes pancreatic cancer progression and immune escape through CSN5-mediated deubiquitination of beta-catenin and PD-L1. Neoplasia. 23, 912\u2013928 (2021).https:\/\/doi.org\/10.1016\/j.neo.2021.07.004","DOI":"10.1016\/j.neo.2021.07.004"},{"key":"1258_CR16","doi-asserted-by":"publisher","first-page":"11051","DOI":"10.2147\/CMAR.S267711","volume":"12","author":"C Yan","year":"2020","unstructured":"C. Yan, X. Song, S. Wang, J. Wang, L. Li, Knockdown of PDIA6 Inhibits Cell Proliferation and Enhances the Chemosensitivity in Gastric Cancer Cells. Cancer Manag Res. 12, 11051\u201311062 (2020). https:\/\/doi.org\/10.2147\/CMAR.S267711","journal-title":"Cancer Manag Res."},{"key":"1258_CR17","doi-asserted-by":"publisher","first-page":"e016615","DOI":"10.1161\/jaha.120.016615","volume":"9","author":"H Qasim","year":"2020","unstructured":"H. Qasim, B.K. McConnell, AKAP12 Signaling Complex: Impacts of Compartmentalizing cAMP-Dependent Signaling Pathways in the Heart and Various Signaling Systems. J. Am. Heart Association. 9, e016615 (2020). https:\/\/doi.org\/10.1161\/jaha.120.016615","journal-title":"J. Am. Heart Association"},{"key":"1258_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/1947601910392984","volume":"1","author":"IH Gelman","year":"2010","unstructured":"I.H. Gelman, Emerging Roles for SSeCKS\/Gravin\/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis. Genes Cancer. 1, 1147\u20131156 (2010). https:\/\/doi.org\/10.1177\/1947601910392984","journal-title":"Genes Cancer"},{"key":"1258_CR19","doi-asserted-by":"publisher","first-page":"215911","DOI":"10.1016\/j.canlet.2022.215911","volume":"549","author":"Y Deng","year":"2022","unstructured":"Y. Deng et al., HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis. Cancer Lett. 549, 215911 (2022). https:\/\/doi.org\/10.1016\/j.canlet.2022.215911","journal-title":"Cancer Lett."},{"key":"1258_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.bbrc.2017.07.043","volume":"490","author":"W Xie","year":"2017","unstructured":"W. Xie, W. Su, L. Zhang, Q. Shang, B. Su, SSeCKS\/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F. Biochem. Biophys. Res. Commun. 490, 1394\u20131398 (2017). https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.043","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1258_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10555-012-9360-1","volume":"31","author":"IH Gelman","year":"2012","unstructured":"I.H. Gelman, Suppression of tumor and metastasis progression through the scaffolding functions of SSeCKS\/Gravin\/AKAP12. Cancer Metastasis Rev. 31, 493\u2013500 (2012). https:\/\/doi.org\/10.1007\/s10555-012-9360-1","journal-title":"Cancer Metastasis Rev."},{"key":"1258_CR22","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1182\/blood-2009-05-219881","volume":"114","author":"T Zhang","year":"2009","unstructured":"T. Zhang et al., Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b\/Src\/beta-catenin pathway. Blood. 114, 4081\u20134088 (2009). https:\/\/doi.org\/10.1182\/blood-2009-05-219881","journal-title":"Blood"},{"key":"1258_CR23","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/sj.onc.1207355","volume":"23","author":"P Fishman","year":"2004","unstructured":"P. Fishman et al., An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. Oncogene. 23, 2465\u20132471 (2004). https:\/\/doi.org\/10.1038\/sj.onc.1207355","journal-title":"Oncogene"},{"key":"1258_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13402-023-00913-7","volume":"47","author":"L Peng","year":"2024","unstructured":"L. Peng et al., OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. Cell. Oncol. (Dordrecht Netherlands). 47, 987\u20131004 (2024). https:\/\/doi.org\/10.1007\/s13402-023-00913-7","journal-title":"Cell. Oncol. (Dordrecht Netherlands)"},{"key":"1258_CR25","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/s41388-024-03056-7","volume":"43","author":"X Li","year":"2024","unstructured":"X. Li et al., TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation. Oncogene. 43, 2063\u20132077 (2024). https:\/\/doi.org\/10.1038\/s41388-024-03056-7","journal-title":"Oncogene"},{"key":"1258_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","volume":"78","author":"J Sun","year":"2023","unstructured":"J. Sun et al., Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J. Hepatol. 78, 627\u2013642 (2023). https:\/\/doi.org\/10.1016\/j.jhep.2022.11.017","journal-title":"J. Hepatol."},{"key":"1258_CR27","doi-asserted-by":"publisher","unstructured":"E.Y. Bakker, M. Fujii, M. Krstic-Demonacos, C. Demonacos, R. Alhammad, Protein disulfide isomerase A1\u2013associated pathways in the development of stratified breast cancer therapies. Int. J. Oncol. 60 (2022). https:\/\/doi.org\/10.3892\/ijo.2022.5306","DOI":"10.3892\/ijo.2022.5306"},{"key":"1258_CR28","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s11033-021-06277-1","volume":"48","author":"MA Diaz Cruz","year":"2021","unstructured":"M.A. Diaz Cruz et al., Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer. Mol. Biol. Rep. 48, 2429\u20132436 (2021). https:\/\/doi.org\/10.1007\/s11033-021-06277-1","journal-title":"Mol. Biol. Rep."},{"key":"1258_CR29","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1128\/mcb.01484-13","volume":"34","author":"A Higa","year":"2014","unstructured":"A. Higa et al., Endoplasmic reticulum stress-activated transcription factor ATF6\u03b1 requires the disulfide isomerase PDIA5 to modulate chemoresistance. Mol. Cell. Biol. 34, 1839\u20131849 (2014). https:\/\/doi.org\/10.1128\/mcb.01484-13","journal-title":"Mol. Cell. Biol."},{"key":"1258_CR30","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1002\/ctm2.606","volume":"12","author":"TY Chen","year":"2022","unstructured":"T.Y. Chen et al., Protein disulfide isomerase a4 promotes lung cancer development via the Stat3 pathway in stromal cells. Clin. translational Med. 12, e606 (2022). https:\/\/doi.org\/10.1002\/ctm2.606","journal-title":"Clin. translational Med."},{"key":"1258_CR31","doi-asserted-by":"publisher","unstructured":"T. Huang et al., WTAP mediated m6A modification stabilizes PDIA3P1 and promotes tumor progression driven by histone lactylation in esophageal squamous cell carcinoma. Adv. Sci. e06529 (2025). https:\/\/doi.org\/10.1002\/advs.202506529","DOI":"10.1002\/advs.202506529"},{"key":"1258_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-023-01758-6","volume":"26","author":"J Tao","year":"2024","unstructured":"J. Tao et al., Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway. Breast cancer research: BCR. 26, 1 (2024). https:\/\/doi.org\/10.1186\/s13058-023-01758-6","journal-title":"Breast cancer research: BCR"},{"key":"1258_CR33","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.ymthe.2024.05.038","volume":"32","author":"CL Yang","year":"2024","unstructured":"C.L. Yang et al., PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2. Mol. therapy: J. Am. Soc. Gene Therapy. 32, 2778\u20132797 (2024). https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.038","journal-title":"Mol. therapy: J. Am. Soc. Gene Therapy"},{"key":"1258_CR34","doi-asserted-by":"publisher","unstructured":"J. Zhao, Y. Li, J. Zhu, H. Li, X. Jin, Ubiquitination in hepatocellular carcinoma immunity. J. translational Med. 23 (2025). https:\/\/doi.org\/10.1186\/s12967-025-06592-2","DOI":"10.1186\/s12967-025-06592-2"},{"key":"1258_CR35","doi-asserted-by":"publisher","first-page":"110994","DOI":"10.1016\/j.cellsig.2023.110994","volume":"114","author":"M Zhang","year":"2024","unstructured":"M. Zhang, T. Wei, D. Guo, The role of abnormal ubiquitination in hepatocellular carcinoma pathology. Cell. Signal. 114, 110994 (2024). https:\/\/doi.org\/10.1016\/j.cellsig.2023.110994","journal-title":"Cell. Signal."},{"key":"1258_CR36","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.7150\/ijbs.113193","volume":"21","author":"X Mi","year":"2025","unstructured":"X. Mi et al., Deubiquitylating Enzymes in Hepatocellular Carcinoma. Int. J. Biol. Sci. 21, 4270\u20134292 (2025). https:\/\/doi.org\/10.7150\/ijbs.113193","journal-title":"Int. J. Biol. Sci."},{"key":"1258_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/hep.0000000000001096","volume":"82","author":"XT Lin","year":"2025","unstructured":"X.T. Lin et al., Integrated ubiquitomics characterization of hepatocellular carcinomas. Hepatol. (Baltimore Md). 82, 42\u201358 (2025). https:\/\/doi.org\/10.1097\/hep.0000000000001096","journal-title":"Hepatol. (Baltimore Md)"},{"key":"1258_CR38","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-024-49087-2","volume":"15","author":"L Luo","year":"2024","unstructured":"L. Luo et al., FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma. Nat. Commun. 15, 4790 (2024). https:\/\/doi.org\/10.1038\/s41467-024-49087-2","journal-title":"Nat. Commun."},{"key":"1258_CR39","doi-asserted-by":"publisher","unstructured":"Q. Zhu et al., YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1. Cell. Mol. Biol. Lett. 30 (2025). https:\/\/doi.org\/10.1186\/s11658-025-00733-7","DOI":"10.1186\/s11658-025-00733-7"},{"key":"1258_CR40","doi-asserted-by":"publisher","unstructured":"M. Guo et al., PIP5K1A suppresses ferroptosis and induces sorafenib resistance by stabilizing NRF2 in hepatocellular carcinoma. Adv. Sci. 12, e04372 (2025). https:\/\/doi.org\/10.1002\/advs.202504372","DOI":"10.1002\/advs.202504372"},{"key":"1258_CR41","doi-asserted-by":"publisher","unstructured":"K. Ramani et al., Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models. eLife. 11 (2022). https:\/\/doi.org\/10.7554\/eLife.78430","DOI":"10.7554\/eLife.78430"},{"key":"1258_CR42","doi-asserted-by":"publisher","unstructured":"C. Thimme Gowda et al., The AKAP12-PKA axis regulates lipid homeostasis during alcohol-associated liver disease. Signal. Transduct. Target. therapy. 10 (2025). https:\/\/doi.org\/10.1038\/s41392-025-02202-1","DOI":"10.1038\/s41392-025-02202-1"},{"key":"1258_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/s0092-8674(02)00970-4","volume":"110","author":"DE Kang","year":"2002","unstructured":"D.E. Kang et al., Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell. 110, 751\u2013762 (2002). https:\/\/doi.org\/10.1016\/s0092-8674(02)00970-4","journal-title":"Cell"},{"key":"1258_CR44","doi-asserted-by":"publisher","unstructured":"C. Drelon et al., PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development. Nat. Commun. 7 (2016). https:\/\/doi.org\/10.1038\/ncomms12751","DOI":"10.1038\/ncomms12751"},{"key":"1258_CR45","doi-asserted-by":"publisher","first-page":"e90229","DOI":"10.1371\/journal.pone.0090229","volume":"9","author":"A Liu","year":"2014","unstructured":"A. Liu et al., Wnt5a through noncanonical Wnt\/JNK or Wnt\/PKC signaling contributes to the differentiation of mesenchymal stem cells into type II alveolar epithelial cells in vitro. PloS one. 9, e90229 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0090229","journal-title":"PloS one"},{"key":"1258_CR46","doi-asserted-by":"publisher","first-page":"e0180711","DOI":"10.1371\/journal.pone.0180711","volume":"12","author":"X Martineau","year":"2017","unstructured":"X. Martineau, \u00c9. Abed, J. Martel-Pelletier, J.P. Pelletier, D. Lajeunesse, Alteration of Wnt5a expression and of the non-canonical Wnt\/PCP and Wnt\/PKC-Ca2\u2009+\u2009pathways in human osteoarthritis osteoblasts. PloS one. 12, e0180711 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0180711","journal-title":"PloS one"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01258-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01258-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:51:43Z","timestamp":1790895103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01258-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1258"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01258-7","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki principles. The tissue samples were collected with the approval of the Ethics Committee and the Medical Records Department of Yichang Central People\u2019s Hospital. (Yichang, China; no.2021-086-01). All animal handling and experimental procedures were approved by the Center for Animal Experiments.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}